How can we best manage biochemical failure after radical prostatectomy?

Biochemical recurrence (BCR) is common after radical prostatectomy, but effective treatment options for men with BCR after curative treatment remain controversial. Although prostate-specific antigen is widely used as a surrogate marker for prostate cancer survival, it cannot fully differentiate betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won Tae, Kim, Jiyeon, Kim, Wun-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643724/
https://www.ncbi.nlm.nih.gov/pubmed/36347548
http://dx.doi.org/10.4111/icu.20220294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643724/
https://www.ncbi.nlm.nih.gov/pubmed/36347548
http://dx.doi.org/10.4111/icu.20220294

Ejemplares similares